Danaher Co. (NYSE:DHR) Stock Holdings Trimmed by Stock Yards Bank & Trust Co.

Stock Yards Bank & Trust Co. cut its position in shares of Danaher Co. (NYSE:DHR) by 3.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 112,146 shares of the conglomerate’s stock after selling 4,350 shares during the quarter. Stock Yards Bank & Trust Co.’s holdings in Danaher were worth $31,179,000 as of its most recent filing with the SEC.

Several other large investors have also bought and sold shares of the company. Anchor Investment Management LLC increased its position in Danaher by 1.3% during the third quarter. Anchor Investment Management LLC now owns 6,039 shares of the conglomerate’s stock worth $1,679,000 after buying an additional 78 shares during the last quarter. Tudor Financial Inc. acquired a new position in Danaher in the 3rd quarter valued at $414,000. Discipline Wealth Solutions LLC bought a new position in shares of Danaher in the third quarter worth about $314,000. Soltis Investment Advisors LLC lifted its holdings in shares of Danaher by 19.3% during the third quarter. Soltis Investment Advisors LLC now owns 1,563 shares of the conglomerate’s stock worth $434,000 after buying an additional 253 shares during the last quarter. Finally, TD Private Client Wealth LLC grew its holdings in shares of Danaher by 1.0% during the 3rd quarter. TD Private Client Wealth LLC now owns 17,946 shares of the conglomerate’s stock worth $4,989,000 after purchasing an additional 169 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

DHR stock opened at $235.44 on Thursday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The firm has a 50-day moving average of $248.34 and a 200 day moving average of $257.78. Danaher Co. has a 1 year low of $218.48 and a 1 year high of $281.70. The company has a market cap of $170.05 billion, a P/E ratio of 44.93, a PEG ratio of 4.23 and a beta of 0.83.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter in the prior year, the firm posted $2.02 earnings per share. The business’s revenue was up 3.1% on a year-over-year basis. On average, sell-side analysts forecast that Danaher Co. will post 7.5 EPS for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be issued a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.46%. Danaher’s payout ratio is 20.61%.

Analysts Set New Price Targets

DHR has been the subject of a number of research analyst reports. Barclays decreased their target price on Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 23rd. KeyCorp boosted their price objective on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Stifel Nicolaus boosted their price target on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. Raymond James decreased their price objective on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Finally, Robert W. Baird dropped their price target on Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $287.16.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.